Welcome to our dedicated page for Encompass Health news (Ticker: EHC), a resource for investors and traders seeking the latest updates and insights on Encompass Health stock.
Encompass Health Corporation (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States, and its news flow reflects ongoing activity across a broad national network. Company announcements frequently highlight new hospital openings, expansion into additional states and joint venture projects with regional health systems.
Recent news releases describe the opening of freestanding inpatient rehabilitation hospitals in markets such as Lake Worth and St. Petersburg in Florida, Amarillo in Texas and Danbury in Connecticut. These hospitals provide intensive physical, occupational and speech therapy, frequent physician visits and 24-hour nursing care for patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions. News items often detail facility features such as private rooms, therapy gyms with advanced rehabilitation technologies, activities of daily living suites, in-house dialysis suites and therapy courtyards.
Encompass Health’s news also covers development plans and partnerships, including joint venture hospitals with organizations like Vanderbilt Health and BSA Health System. These stories explain how new inpatient rehabilitation hospitals are intended to complement existing acute care services and expand access to hospital-level rehabilitative care in specific regions.
Investors and observers will also find financial and corporate updates in the company’s news, such as quarterly earnings results, guidance updates and dividend declarations. The company issues press releases summarizing its operating results, non-GAAP measures like Adjusted EBITDA and adjusted earnings per share, and information about investor conference calls and webcasts.
This news page aggregates these various categories of information, allowing readers to follow Encompass Health’s hospital openings, geographic expansion, partnerships, financial disclosures and industry recognitions in one place.
Encompass Health (EHC) and Lee Health have announced the opening of the Rehabilitation Hospital of Fort Myers in Florida. The 60-bed inpatient rehabilitation facility, located at 6150 Medical Park Loop, represents Encompass Health's 168th rehabilitation hospital nationwide and 22nd location in Florida. The facility specializes in treating patients recovering from strokes, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions.
The hospital features private patient rooms, advanced rehabilitation technologies, an in-house dialysis suite, therapy courtyard, and comprehensive amenities. Patients receive minimum three hours of intensive therapy five days weekly, frequent physician visits, and 24-hour nursing care. The facility employs an interdisciplinary team of specialized nurses, therapists, and physicians providing physical, occupational, and speech therapies.
Encompass Health (NYSE: EHC) has revealed plans to construct a new 50-bed inpatient rehabilitation hospital in Apollo Beach, Florida's Waterset community. The facility will provide specialized care for patients recovering from various conditions including strokes, neurological disorders, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions.
The state-of-the-art hospital will feature private rooms, advanced rehabilitation technologies, an activities suite, in-house dialysis, pharmacy, and therapy courtyard. The facility is scheduled to open in 2027 as part of Encompass Health's national network expansion in Florida, aiming to provide closer-to-home rehabilitative care for Apollo Beach area residents.
Encompass Health (EHC) has announced its 2025 research grant program, offering up to $60,000 in funding for research projects focused on post-acute care therapies and rehabilitation. Applications are due by September 30, 2025, with winners announced by October 30, 2025. The program welcomes studies on therapy effectiveness, neurological impairments, patient outcomes, and implementation science.
Research projects must be completed within 12 months of receiving the grant and conducted in the United States or Puerto Rico. Notably, applicants don't need to be affiliated with Encompass Health, and research can be conducted outside their facilities. Applications will be evaluated based on scientific merit, investigator experience, relevance, expected outcomes, and feasibility.
Encompass Health (NYSE: EHC) has announced a quarterly cash dividend declaration of $0.17 per share. The dividend will be paid on July 15, 2025, to shareholders who are registered as holders of record on July 1, 2025. This dividend announcement demonstrates the company's commitment to providing regular returns to its shareholders.
Encompass Health (NYSE: EHC) has announced its upcoming participation in the BofA Securities 2025 Healthcare Conference. The conference is scheduled for May 13-15, 2025, in what represents an important opportunity for the company to engage with the investment community.
Key details of the participation include:
- Speaker: Doug Coltharp, Executive Vice President and Chief Financial Officer
- Format: Fireside chat
- Date and Time: Tuesday, May 13, 2025, from 8:40-9:10 a.m. PT
- Accessibility: The presentation will be available via live webcast
- Viewing Option: Interested parties can access the webcast through investor.encompasshealth.com
This participation highlights Encompass Health's commitment to maintaining transparent communication with investors and analysts while providing insights into their business strategies and market position.
Encompass Health (NYSE: EHC) has promoted Patrick Tuer to the newly created position of Chief Operating Officer (COO), effective immediately. Tuer, previously serving as group president overseeing 69 hospitals across three geographic regions, will now manage hospital operations across the entire organization, reporting to CEO Mark Tarr.
The promotion comes amid significant growth through the company's accelerated de novo program and capacity additions to existing hospitals. Since joining in 2018, Tuer has held various leadership roles including regional president and regional vice president, demonstrating success in driving volume growth, operational improvements, and enhanced patient outcomes.
The appointment aligns with Encompass Health's strategy of expanding access to rehabilitative care while improving performance across their operations. The company reports having a robust development pipeline with expectations for continued growth.
Encompass Health (NYSE: EHC) reported strong Q1 2025 financial results with significant growth across key metrics. Net operating revenue increased 10.6% to $1,455.4 million, driven by a 6.3% growth in total discharges and a 3.9% increase in net patient revenue per discharge.
The company's performance showed notable improvements with income from continuing operations per diluted share rising 33.3% to $1.48, while adjusted earnings per share grew 22.3% to $1.37. Cash flows from operating activities increased 20.9% to $288.6 million, and Adjusted EBITDA rose 14.9% to $313.6 million.
During Q1, EHC expanded its capacity by opening a new 40-bed hospital and adding 25 beds to existing facilities. Based on strong performance, the company increased its full-year 2025 guidance, projecting net operating revenue of $5,850-$5,925 million and adjusted earnings per share of $4.85-$5.10.
Encompass Health (NYSE: EHC) has announced plans to construct a new 50-bed inpatient rehabilitation hospital in St. George, Utah. The freestanding facility, set to open in 2027, will be the company's second location in Utah.
The hospital will provide specialized care for patients recovering from various conditions including strokes, neurological disorders, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions. The facility will feature private patient rooms, advanced rehabilitation technologies, an activities of daily living suite, in-house dialysis suite, pharmacy, and therapy courtyard.
The new facility will offer 24-hour nursing care along with physical, occupational, and speech therapies, delivered by specialized healthcare professionals to help restore patients' functional ability and quality of life.
Encompass Health (NYSE: EHC) has announced its annual stockholder meeting will be held virtually on Thursday, May 1, 2025 at 11:00 a.m. CDT.
Stockholders of record as of March 7, 2025 can participate in the meeting through virtualshareholdermeeting.com/EHC2025. To join or vote, stockholders must use their 16-digit control number found on their Notice of Internet Availability of Proxy Materials or proxy card.
The virtual meeting platform will be accessible 15 minutes before the start time, and an archived recording will be available for replay after the event.
Encompass Health (NYSE: EHC) has announced a change in the timing of its 2025 first quarter earnings conference call, which will now take place at 9 a.m. ET on Friday, April 25, 2025, instead of the previously scheduled 10 a.m. ET time slot.
The company will release its Q1 2025 financial results, covering the period ended March 31, 2025, after market close on Thursday, April 24, 2025. Investors can join the conference call by dialing 800-245-3047 (US) or 203-518-9765 (International) with the conference ID EHCQ125. A live webcast and replay will be available on the company's investor website.
FAQ
What is the current stock price of Encompass Health (EHC)?
What is the market cap of Encompass Health (EHC)?
